PharmAthene Inc.: Government giving Emergent BioSolutions unfair advantage in anthrax contracting

Annapolis-based biodefense company PharmAthene Inc. filed a complaint against the Department of Health and Human Services, claiming it is giving a de facto sole-source anthrax contract to competitor Emergent BioSolutions Inc. with its latest solicitation. In a protest filed with the U.S. Government Accountability Office, officials from PharmAthene said the solicitation was written in a way that eliminated competition and ensured that an award for a next-generation anthrax vaccine would go to Gaithersburg-based…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news